198 related articles for article (PubMed ID: 26057489)
1. Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.
Ahmed SG; Kagu MB; Ibrahim UA; Bukar AA
Blood Transfus; 2015 Oct; 13(4):639-43. PubMed ID: 26057489
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Protective Effect of Sickle Cell Trait and Blood Group-O on the Risk of Endemic Burkitt's Lymphoma.
Ahamed SG; Ibrahim UA; Kagu MB
Gulf J Oncolog; 2018 Sep; 1(28):11-16. PubMed ID: 30344128
[TBL] [Abstract][Full Text] [Related]
3. Association of the sickle cell trait and the ABO blood group with clinical severity of malaria in southwest Nigeria.
Amodu OK; Olaniyan SA; Adeyemo AA; Troye-Blomberg M; Olumese PE; Omotade OO
Acta Trop; 2012 Aug; 123(2):72-7. PubMed ID: 22503377
[TBL] [Abstract][Full Text] [Related]
4. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
Vasan SK; Rostgaard K; Majeed A; Ullum H; Titlestad KE; Pedersen OB; Erikstrup C; Nielsen KR; Melbye M; Nyrén O; Hjalgrim H; Edgren G
Circulation; 2016 Apr; 133(15):1449-57; discussion 1457. PubMed ID: 26939588
[TBL] [Abstract][Full Text] [Related]
5. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
6. An investigation of sickle cell trait, body mass index, and fitness in relation to venous thromboembolism among African American adults.
Nelson DA; Deuster PA; O'Connor FG; Edgeworth DB; Kurina LM
J Thromb Haemost; 2021 Sep; 19(9):2216-2224. PubMed ID: 34105875
[TBL] [Abstract][Full Text] [Related]
7. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
[TBL] [Abstract][Full Text] [Related]
8. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
Gupta S; Carmona R; Malvar J; Young G
Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
[TBL] [Abstract][Full Text] [Related]
9. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Zotz RB
Thromb Haemost; 2003 Jul; 90(1):77-85. PubMed ID: 12876629
[TBL] [Abstract][Full Text] [Related]
10. Differences in limb, age and sex of Chinese deep vein thrombosis patients.
Chen F; Xiong JX; Zhou WM
Phlebology; 2015 May; 30(4):242-8. PubMed ID: 24531804
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study.
van Langevelde K; Lijfering WM; Rosendaal FR; Cannegieter SC
Blood; 2011 Oct; 118(15):4239-41. PubMed ID: 21849479
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell trait and the risk of venous thromboembolism among blacks.
Austin H; Key NS; Benson JM; Lally C; Dowling NF; Whitsett C; Hooper WC
Blood; 2007 Aug; 110(3):908-12. PubMed ID: 17409269
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors.
Hirmerova J; Seidlerova J; Subrt I
Int Angiol; 2013 Aug; 32(4):410-6. PubMed ID: 23822944
[TBL] [Abstract][Full Text] [Related]
15. Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects.
Guzmán N; Salazar LA
Genet Test Mol Biomarkers; 2010 Oct; 14(5):599-602. PubMed ID: 20707729
[TBL] [Abstract][Full Text] [Related]
16. [Risk of thromboembolic phenomena in patients with inflammatory bowel disease].
Suárez Ferrer C; Vera Mendoza MI; Amo San Román L; González Lama Y; Calvo Moya M; García Casas M; Abreu García L
Gastroenterol Hepatol; 2012 Nov; 35(9):634-9. PubMed ID: 23036695
[TBL] [Abstract][Full Text] [Related]
17. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
Sallah S; Wan JY; Nguyen NP
Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
[TBL] [Abstract][Full Text] [Related]
18. Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis.
Dentali F; Di Minno MN; Turato S; Crestani S; Ambrosino P; Bonfanti C; Di Minno G; Ageno W; Franchini M
Thromb Res; 2014 Aug; 134(2):264-7. PubMed ID: 24882273
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
20. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors.
Kim YH; Kim JS
Clin Orthop Relat Res; 2007 Dec; 465():33-9. PubMed ID: 17693875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
